Ulrich Lehmann

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

JCO precision oncology

Cancers

Clinical epigenetics

British journal of cancer

Hannover Medical School

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hannover Medical School Nov 01 2009

Germany

Professor of Molcular Pathology :: Institute of Pathology

Publications

Ulrich Lehmann
Epigenetic Therapies in Triple-Negative Breast Cancer: Concepts, Visions, and Challenges. Cancers 16 (12) (2024)
Nicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, Sabine Merkelbach-Bruse, Janna Siemanowski, Eva-Maria Mayr, Sylvia Herold, Karsten Kleo, Lukas C Heukamp, Eva Maria Willing, Michael Menzel, Ulrich Lehmann, Stephan Bartels, Shounak Chakraborty, Gustavo Baretton, Melanie C Demes, Claudia Döring, Daniel N Kazdal, Jan Budczies, Roland Rad, Peter Wild, Yann Christinat, Thomas A McKee, Peter Schirmacher, David Horst, Reinhard Buttner, Albrecht Stenzinger, Jalid Sehouli, Claudia Vollbrecht, Michael Hummel, Elena I Braicu, Wilko Weichert, null null
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer. JCO precision oncology 8 (2024)
Ulrich Lehmann
Epigenetic Therapies in Triple-Negative Breast Cancer: Concepts, Visions, and Challenges. Cancers 16 (12) (2024)
Nicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, Sabine Merkelbach-Bruse, Janna Siemanowski, Eva-Maria Mayr, Sylvia Herold, Karsten Kleo, Lukas C Heukamp, Eva Maria Willing, Michael Menzel, Ulrich Lehmann, Stephan Bartels, Shounak Chakraborty, Gustavo Baretton, Melanie C Demes, Claudia Döring, Daniel N Kazdal, Jan Budczies, Roland Rad, Peter Wild, Yann Christinat, Thomas A McKee, Peter Schirmacher, David Horst, Reinhard Buttner, Albrecht Stenzinger, Jalid Sehouli, Claudia Vollbrecht, Michael Hummel, Elena I Braicu, Wilko Weichert, null null
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer. JCO precision oncology 8 (2024)
Nicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, Sabine Merkelbach-Bruse, Janna Siemanowski, Eva-Maria Mayr, Sylvia Herold, Karsten Kleo, Lukas C Heukamp, Eva Maria Willing, Michael Menzel, Ulrich Lehmann, Stephan Bartels, Shounak Chakraborty, Gustavo Baretton, Melanie C Demes, Claudia Döring, Daniel N Kazdal, Jan Budczies, Roland Rad, Peter Wild, Yann Christinat, Thomas A McKee, Peter Schirmacher, David Horst, Reinhard Buttner, Albrecht Stenzinger, Jalid Sehouli, Claudia Vollbrecht, Michael Hummel, Elena I Braicu, Wilko Weichert, null null
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer. JCO precision oncology 8 (2024)
Olaf Neumann, Timothy C Burn, Michael Allgäuer, Markus Ball, Martina Kirchner, Thomas Albrecht, Anna-Lena Volckmar, Susanne Beck, Volker Endris, Hannah Goldschmid, Ulrich Lehmann, Huriye Seker-Cin, Sebastian Uhrig, Stephanie Roessler, Jan Budczies, Stefan Fröhling, Thomas Longerich, Alex H Wagner, Arndt Vogel, Peter Schirmacher, Albrecht Stenzinger, Daniel N Kazdal
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing. British journal of cancer 127 (8) (2022)
Lara Bücker, Ulrich Lehmann
CDH1 ( E-cadherin ) Gene Methylation in Human Breast Cancer: Critical Appraisal of a Long and Twisted Story. Cancers 14 (18) (2022)
Isabel Grote, Stephan Bartels, Henriette Christgen, Martin Radner, Malte Gronewold, Leonie Kandt, Mieke Raap, Ulrich Lehmann, Oleg Gluz, Monika Graeser, Sherko Kuemmel, Ulrike Nitz, Nadia Harbeck, Hans Kreipe, Matthias Christgen
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 35 (12) (2022)
Ulrich Lehmann, Helge Stark, Stephan Bartels, Jerome Schlue, Guntram Büsche, Hans Kreipe
Genome-wide DNA methylation profiling is able to identify prefibrotic PMF cases at risk for progression to myelofibrosis. Clinical epigenetics 13 (1) (2021)
Stephanie Busche, Katharina John, Franziska Wandrer, Florian W R Vondran, Ulrich Lehmann, Heiner Wedemeyer, Frank Essmann, Heike Bantel, Heike Bantel
BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatment. Cell death & disease 12 (8) (2021)
Sumadi Lukman Anwar, Britta Hasemeier, Elisa Schipper, Arndt Vogel, Hans Kreipe, Ulrich Lehmann
LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype. PloS one 14 (5) (2019)

Ulrich Lehmann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ulrich Lehmann